1:22-CV-00252
02/28/2022
Pending - Other Pending
Intellectual Property - Patent
Maryellen Noreika
Arbutus Biopharma Corporation
Genevant Sciences GmbH
Moderna, Inc.
ModernaTX, Inc.
John W. Shaw
Attorney at Shaw Keller LLP
I.M. Pei Building, 1105 North Market Street
Wilmington, DE 19801
Karen Elizabeth Keller
Attorney at Shaw Keller LLP
1105 North Market Street, 12Th Floor
Wilmington, DE 19801
Adam D. Harber
Daralyn J. Durie
David I. Berl
Denis R Hurley
Eric C. Wiener
Jessica Palmer Ryen
Lydia B Cash
Thomas S. Fletcher
Brian P. Egan
Attorney at Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Wilmington, DE 19899
Jack B. Blumenfeld
Attorney at Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Wilmington, DE 19899
(#13) MOTION for Pro Hac Vice Appearance of Attorney Adam D. Harber - filed by Arbutus Biopharma Corporation, Genevant Sciences GmbH. (Keller, Karen) (Entered: 03/17/2022)
(#12) MOTION for Pro Hac Vice Appearance of Attorney Daralyn J. Durie and Eric C. Wiener - filed by Arbutus Biopharma Corporation, Genevant Sciences GmbH. (Keller, Karen) (Entered: 03/15/2022)
(#11) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Thomas S. Fletcher, Jessica Palmer Ryen, Denis R. Hurley and Lydia B. Cash - filed by Arbutus Biopharma Corporation, Genevant Sciences GmbH. (Keller, Karen) (Entered: 03/15/2022)
(#10) STIPULATION TO EXTEND TIME for the defendants to move, answer, or otherwise respond to the Complaint to May 6, 2022 - filed by Moderna, Inc., ModernaTX, Inc.. (Blumenfeld, Jack) (Entered: 03/07/2022)
SO ORDERED re #9 MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Patricia A. Carson, Jeanna M. Wacker and Mark C. McLennan filed by Moderna, Inc., ModernaTX, Inc. ORDERED by Judge Maryellen Noreika on 3/3/2022. (dlw) (Entered: 03/03/2022)
(#6) Summons Issued with Magistrate Consent Notice attached as to Moderna, Inc. on 2/28/2022; ModernaTX, Inc. on 2/28/2022. (Attachments: #1 Summons Issued Modernatx)(mal) (Entered: 02/28/2022)
(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roivant Sciences Ltd. for Genevant Sciences GmbH. Roivant Sciences Ltd., a publicly-held company, owns 10% or more of the stock of Arbutus Biopharma Corp. - filed by Arbutus Biopharma Corporation and Genevant Sciences GmbH. (mal) (Entered: 02/28/2022)
(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,141,378 B2. (mal) (Entered: 02/28/2022)
(#3) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,058,069 B2 ;US 8,492,359 B2 ;US 8,822,668 B2 ;US 9,364,435 B2 ;US 9,504,651 B2. (mal) (Entered: 02/28/2022)
(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) (Entered: 02/28/2022)
Civil Cover Sheet
Exhibit F
Exhibit E
Exhibit D
Exhibit C
Exhibit B
Exhibit A
(#1) COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Moderna, Inc., ModernaTX, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3812080.) - filed by Genevant Sciences GmbH, Arbutus Biopharma Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Civil Cover Sheet)(mal) (Entered: 02/28/2022)
DocketPro Hac Vice Attorney Adam D. Harber for Genevant Sciences GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) (Entered: 03/21/2022)
DocketSO ORDERED re #13 MOTION for Pro Hac Vice Appearance of Attorney Adam D. Harber filed by Genevant Sciences GmbH, Arbutus Biopharma Corporation. ORDERED by Judge Maryellen Noreika on 3/18/2022. (dlw) (Entered: 03/18/2022)
Docket(#13) MOTION for Pro Hac Vice Appearance of Attorney Adam D. Harber - filed by Arbutus Biopharma Corporation, Genevant Sciences GmbH. (Keller, Karen) (Entered: 03/17/2022)
DocketPro Hac Vice Attorney David I. Berl, Thomas S. Fletcher, Denis R Hurley, Jessica Palmer Ryen, Lydia B Cash, Daralyn J. Durie, and Eric C. Wiener for Genevant Sciences GmbH added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 03/17/2022)
DocketSO ORDERED re #12 MOTION for Pro Hac Vice Appearance of Attorney Daralyn J. Durie and Eric C. Wiener, #11 MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Thomas S. Fletcher, Jessica Palmer Ryen, Denis R. Hurley and Lydia B. Cash filed by Genevant Sciences GmbH, Arbutus Biopharma Corporation. ORDERED by Judge Maryellen Noreika on 3/15/2022. (dlw) (Entered: 03/15/2022)
Docket(#12) MOTION for Pro Hac Vice Appearance of Attorney Daralyn J. Durie and Eric C. Wiener - filed by Arbutus Biopharma Corporation, Genevant Sciences GmbH. (Keller, Karen) (Entered: 03/15/2022)
Docket(#11) MOTION for Pro Hac Vice Appearance of Attorney David I. Berl, Thomas S. Fletcher, Jessica Palmer Ryen, Denis R. Hurley and Lydia B. Cash - filed by Arbutus Biopharma Corporation, Genevant Sciences GmbH. (Keller, Karen) (Entered: 03/15/2022)
DocketSO ORDERED re #10 STIPULATION TO EXTEND TIME for the defendants to move, answer, or otherwise respond to the Complaint to May 6, 2022 (Set/Reset Answer Deadlines: Moderna, Inc. answer due 5/6/2022; ModernaTX, Inc. answer due 5/6/2022). ORDERED by Judge Maryellen Noreika on 3/7/2022. (dlw) (Entered: 03/07/2022)
Docket(#10) STIPULATION TO EXTEND TIME for the defendants to move, answer, or otherwise respond to the Complaint to May 6, 2022 - filed by Moderna, Inc., ModernaTX, Inc.. (Blumenfeld, Jack) (Entered: 03/07/2022)
DocketSO ORDERED re #9 MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Patricia A. Carson, Jeanna M. Wacker and Mark C. McLennan filed by Moderna, Inc., ModernaTX, Inc. ORDERED by Judge Maryellen Noreika on 3/3/2022. (dlw) (Entered: 03/03/2022)
Docket(#9) MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Patricia A. Carson, Jeanna M. Wacker and Mark C. McLennan - filed by Moderna, Inc., ModernaTX, Inc.. (Blumenfeld, Jack) (Entered: 03/02/2022)
Docket(#8) SUMMONS Returned Executed by Genevant Sciences GmbH, Arbutus Biopharma Corporation. ModernaTX, Inc. served on 3/1/2022, answer due 3/22/2022. (Shaw, John) (Entered: 03/02/2022)
Docket(#7) SUMMONS Returned Executed by Genevant Sciences GmbH, Arbutus Biopharma Corporation. Moderna, Inc. served on 3/1/2022, answer due 3/22/2022. (Shaw, John) (Entered: 03/02/2022)
DocketCase Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 03/02/2022)
Docket(#6) Summons Issued with Magistrate Consent Notice attached as to Moderna, Inc. on 2/28/2022; ModernaTX, Inc. on 2/28/2022. (Attachments: #1 Summons Issued Modernatx)(mal) (Entered: 02/28/2022)
Docket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roivant Sciences Ltd. for Genevant Sciences GmbH. Roivant Sciences Ltd., a publicly-held company, owns 10% or more of the stock of Arbutus Biopharma Corp. - filed by Arbutus Biopharma Corporation and Genevant Sciences GmbH. (mal) (Entered: 02/28/2022)
Docket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 11,141,378 B2. (mal) (Entered: 02/28/2022)
Docket(#3) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,058,069 B2 ;US 8,492,359 B2 ;US 8,822,668 B2 ;US 9,364,435 B2 ;US 9,504,651 B2. (mal) (Entered: 02/28/2022)
Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) (Entered: 02/28/2022)
Docket(#1) COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Moderna, Inc., ModernaTX, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3812080.) - filed by Genevant Sciences GmbH, Arbutus Biopharma Corporation. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Civil Cover Sheet)(mal) (Entered: 02/28/2022)
Dig Deeper
Get Deeper Insights on Court Cases